Keenan TDL. Comment on "Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration". Am J Ophthalmol 2025 May 8:S0002-9394(25)00228.
PMID: 40348352